Harvard Bioscience, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of HBIO for the last quarter is 21.97 M USD, and it's 4.88% lower compared to the previous quarter. The net income of Q3 24 is -4.80 M USD.